Indeed, similar findings were observed of murine melanoma tumors (YUMM3.3 and B16F10) grown in athymic mice that do not have mature T cells, which were completely resistant to RGS (Suppl.Fig. 13), suggesting that the adaptive immune system is indispensable for the RGS-induced anti-tumor effects. The gene discussed is PITX2; the disease is melanoma.